AGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Allergan Inc's quarterly cash and cash equivalents increased from Sep. 2013 ($2,686 Mil) to Dec. 2013 ($3,046 Mil) but then declined from Dec. 2013 ($3,046 Mil) to Mar. 2014 ($2,815 Mil).
Allergan Inc's annual cash and cash equivalents increased from Dec. 2011 ($2,406 Mil) to Dec. 2012 ($2,702 Mil) and increased from Dec. 2012 ($2,702 Mil) to Dec. 2013 ($3,046 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Allergan Inc Annual Data
Allergan Inc Quarterly Data